The death domain kinase RIP protects thymocytes from tumor necrosis factor receptor type 2-induced cell death

Journal of Experimental Medicine

Volumn 196, Issue 1, 2002, Pages 15-26

  Cusson, Nicole ^a   Oikemus, Sarah ^a   Kilpatrick, Elizabeth D ^a   Cunningham, Leslie ^a   Kelliher, Michelle ^a,b  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

NF B; RIP; Thymocyte survival; TNFK2; TNFR1

Indexed keywords

FAS ANTIGEN; PROTEIN; PROTEIN RIP; RECEPTOR INTERACTING PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE; BONE MARROW CELL; CELL DEATH; CELL LINEAGE; CELL SURVIVAL; CONTROLLED STUDY; FIBROBLAST; GENE MUTATION; GENETIC RECOMBINATION; HEMATOPOIESIS; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; THYMOCYTE;

ANIMALS; ANTIGENS, CD; APOPTOSIS; CELL DIFFERENTIATION; CELL SURVIVAL; FLOW CYTOMETRY; GENE TARGETING; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HETEROZYGOTE; HOMOZYGOTE; LIVER; LYMPHOCYTES; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; NF-KAPPA B; PROTEINS; RADIATION CHIMERA; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASES; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; T-LYMPHOCYTES; THYMUS GLAND;

EID: 0036645407     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20011470     Document Type: Article

References (41)

1. Mature T lymphocyte apoptosis-immune regulation in a dynamic and unpredictable antigenic environment
2. T cell growth cytokines cause the superinduction of molecules mediating antigen-induced T lymphocyte death
3. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis
4. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family
5. Generalized lymphoproliferative disease in mice caused by a point mutation in the Fas ligand
6. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis
7. Gld/gld mice are unable to express a functional ligand for Fas
8. Signaling by the TNF receptor superfamily and T cell homeostasis
9. MHC class II-associated variation in the production of tumor necrosis factor in mice and humans: Relevance to the pathogenesis of autoimmune diseases
10. Cytotoxic effect of TNF and lymphotoxin on T lymphoblasts
11. Induction of apoptosis in mature T cells by tumour necrosis factor
12. Requirement for TNF-α and IL-α in fetal thymocyte commitment and differentiation
13. Surface T cell Fas receptor/CD95 regulation, in vivo activation and apoptosis. Activation-induced death can occur without Fas receptor
14. Tumor necrosis factor receptor p55 mediates deletion of peripheral cytotoxic T lymphocytes in vivo
15. The roles of Fas/APO-1 (CD95) and TNF in antigen-induced programmed cell death in T cell receptor transgenic mice
16. Characterization of tumor necrosis factor-deficient mice
17. The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation and death
18. Tumor necrosis factor (TNF) receptor expression in T lymphocytes. Differential regulation of the type 1 TNF receptor during activation of resting and effector T cells
19. An essential role for NF-κB in preventing TNFα-induced cell death
20. Suppression of TNFα-induced apoptosis by NF-κB
21. The IKKβ subunit of IκB kinase (IKK) is essential for nuclear factor-kB activation and prevention of apoptosis
22. Inhibition of NF-κB/Rel induces apoptosis of murine B cells
23. RIP mediates tumor necrosis factor receptor type 1 activation of NF-κB but not Fas/APO-1-initiated apoptosis
24. The death domain kinase RIP mediates the TNF-induced NF-κB signal
25. The two different receptors for tumor necrosis factor mediate distinct cellular responses
26. TNF receptor type 2 mediates thymocyte proliferation independently of TNF receptor type 1
27. Induction of cell death by tumour necrosis factor (TNF) receptor type 2, CD40 and CD30: A role for TNF-R1 activation by endogenous membrane-anchored TNF
28. Stimulation of human T cell proliferation by specific activation of the 75kDa tumor necrosis factor receptor
29. Regulated commitment of TNF receptor signaling: A molecular switch of death or activation
30. A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor
31. TRAF2-mediated activation of NF-kappa-B by TNF receptor 2 and CD40
32. The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins
33. TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several modes of inflammation
34. Fas-mediated apoptosis and activation-induced T cell proliferation are defective in mice lacking FADD/Mort 1
35. Absence of tumor necrosis factor rescues RelA-deficient mice from embryonic lethality
36. Prevention of hepatic apoptosis and embryonic lethality in relA/TNFR-1 double knockout mice
37. IKK-β is essential for protecting T cells from TNF-α-induced apoptosis
38. TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex
39. Fadd/Mort 1 regulates the pre-TCR checkpoint and can function as a tumour suppressor
40. NF-κB activation by the pre-T cell receptor serves as a selective survival signal in T lymphocyte development. 2000
41. TNF-RII and c-IAP1 mediate ubiquitination and degradation of TRAF2